BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 16498060)

  • 1. Low-density lipoprotein apolipoprotein B100 turnover in hypopituitary patients with GH deficiency: a stable isotope study.
    Christ ER; Cummings MH; Stolinski M; Jackson N; Lumb PJ; Wierzbicki AS; Sönksen PH; Russell-Jones DL; Umpleby AM
    Eur J Endocrinol; 2006 Mar; 154(3):459-66. PubMed ID: 16498060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of short- and long-term growth hormone replacement on lipoprotein composition and on very-low-density lipoprotein and low-density lipoprotein apolipoprotein B100 kinetics in growth hormone-deficient hypopituitary subjects.
    Kearney T; de Gallegos CN; Proudler A; Parker K; Anayaoku V; Bannister P; Venkatesan S; Johnston DG
    Metabolism; 2003 Jan; 52(1):50-9. PubMed ID: 12524662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of growth hormone (GH) replacement therapy on low-density lipoprotein apolipoprotein B100 kinetics in adult patients with GH deficiency: a stable isotope study.
    Christ ER; Cummings MH; Jackson N; Stolinski M; Lumb PJ; Wierzbicki AS; Sönksen PH; Russell-Jones DL; Umpleby AM
    J Clin Endocrinol Metab; 2004 Apr; 89(4):1801-7. PubMed ID: 15070948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of growth hormone treatment on very-low density lipoprotein apolipoprotein B100 turnover in adult hypopituitarism.
    Chrisoulidou A; Kousta E; Venkatesan S; Gray R; Bannister PA; Gallagher JJ; Lawrence N; Johnston DG
    Metabolism; 2000 May; 49(5):563-6. PubMed ID: 10831163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low density lipoprotein particle size in hypopituitary adults receiving conventional hormone replacement therapy.
    O'Neal D; Hew FL; Sikaris K; Ward G; Alford F; Best JD
    J Clin Endocrinol Metab; 1996 Jul; 81(7):2448-54. PubMed ID: 8675559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fasting and postprandial lipid abnormalities in hypopituitary women receiving conventional replacement therapy.
    al-Shoumer KA; Cox KH; Hughes CL; Richmond W; Johnston DG
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2653-9. PubMed ID: 9253349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of 24 months recombinant human growth hormone (rh-GH) on LDL cholesterol, triglyceride-rich lipoproteins and apo [a] in hypopituitary adults previously treated with conventional replacement therapy.
    O'Neal DN; Hew FL; Best JD; Alford F
    Growth Horm IGF Res; 1999 Jun; 9(3):165-73. PubMed ID: 10502452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determinants of cardiovascular risk in 2589 hypopituitary GH-deficient adults - a KIMS database analysis.
    Abs R; Feldt-Rasmussen U; Mattsson AF; Monson JP; Bengtsson BA; Góth MI; Wilton P; Koltowska-Häggström M
    Eur J Endocrinol; 2006 Jul; 155(1):79-90. PubMed ID: 16793953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormalities of very low density lipoprotein apolipoprotein B-100 metabolism contribute to the dyslipidaemia of adult growth hormone deficiency.
    Cummings MH; Christ E; Umpleby AM; Albany E; Wierzbicki A; Lumb PJ; Sönksen PH; Russell-Jones DL
    J Clin Endocrinol Metab; 1997 Jun; 82(6):2010-3. PubMed ID: 9177423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of growth hormone (GH) replacement therapy on very low density lipoprotein apolipoprotein B100 kinetics in patients with adult GH deficiency: a stable isotope study.
    Christ ER; Cummings MH; Albany E; Umpleby AM; Lumb PJ; Wierzbicki AS; Naoumova RP; Boroujerdi MA; Sönksen PH; Russell-Jones DL
    J Clin Endocrinol Metab; 1999 Jan; 84(1):307-16. PubMed ID: 9920100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atherogenic lipoprotein phenotype and low-density lipoprotein size and subclasses in patients with growth hormone deficiency before and after short-term replacement therapy.
    Rizzo M; Trepp R; Berneis K; Christ ER
    Eur J Endocrinol; 2007 Mar; 156(3):361-7. PubMed ID: 17322496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypopituitarsim is associated with triglyceride enrichment of very low-density lipoprotein.
    Kearney T; Navas de Gallegos C; Chrisoulidou A; Gray R; Bannister P; Venkatesan S; Johnston DG
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3900-6. PubMed ID: 11502830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coronary risk in growth hormone deficient hypopituitary adults: increased predicted risk is due largely to lipid profile abnormalities.
    Abdu TA; Neary R; Elhadd TA; Akber M; Clayton RN
    Clin Endocrinol (Oxf); 2001 Aug; 55(2):209-16. PubMed ID: 11531927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aspects of growth hormone deficiency and replacement in elderly hypopituitary adults.
    Feldt-Rasmussen U; Wilton P; Jonsson P; ;
    Growth Horm IGF Res; 2004 Jun; 14 Suppl A():S51-8. PubMed ID: 15135778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of abdominal visceral fat, growth hormone, fitness, and insulin on lipids and lipoproteins in older adults.
    Weltman A; Despres JP; Clasey JL; Weltman JY; Wideman L; Kanaley J; Patrie J; Bergeron J; Thorner MO; Bouchard C; Hartman ML
    Metabolism; 2003 Jan; 52(1):73-80. PubMed ID: 12524665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Normal VLDL metabolism despite altered lipoprotein composition in type 1 diabetes mellitus.
    Christ ER; Carroll PV; Albany E; Umpleby AM; Lumb PJ; Wierzbicki AS; Simpson HL; Sönksen PH; Russell-Ones DL
    Clin Endocrinol (Oxf); 2001 Dec; 55(6):777-87. PubMed ID: 11895220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of glucocorticoid replacement regimens on metabolic outcome and comorbidity in hypopituitary patients.
    Filipsson H; Monson JP; Koltowska-Häggström M; Mattsson A; Johannsson G
    J Clin Endocrinol Metab; 2006 Oct; 91(10):3954-61. PubMed ID: 16895963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth hormone (GH) replacement decreases serum total and LDL-cholesterol in hypopituitary patients on maintenance HMG CoA reductase inhibitor (statin) therapy.
    Monson JP; Jönsson P; Koltowska-Häggström M; Kourides I
    Clin Endocrinol (Oxf); 2007 Oct; 67(4):623-8. PubMed ID: 17581260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A nine-month, placebo-controlled study of the effects of growth hormone treatment on lipoproteins and LDL size in abdominally obese men.
    Svensson J; Bengtsson BA; Taskinen MR; Wiklund O; Johannsson G
    Growth Horm IGF Res; 2000 Jun; 10(3):118-26. PubMed ID: 10942632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum lipid and leptin concentrations in hypopituitary patients with growth hormone deficiency.
    Ozbey N; Algun E; Turgut AS; Orhan Y; Sencer E; Molvalilar S
    Int J Obes Relat Metab Disord; 2000 May; 24(5):619-26. PubMed ID: 10849585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.